Massive study hints diabetes drug may shield brain from dementia
NCT ID NCT05768945
First seen Nov 11, 2025 · Last updated May 23, 2026 · Updated 20 times
Summary
This study analyzed health records from over 740,000 older adults with diabetes to see if certain diabetes medications, like semaglutide, are linked to a lower risk of developing dementia or Alzheimer's disease. Researchers compared people taking semaglutide to those on other diabetes drugs and tracked who developed dementia over time. The goal was to find if these medicines could be repurposed to protect brain health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.